ARCHIVES

In Brief: FDA Changes Package Inserts For Thiotepa, Cyclophosphamide, As Committee Suggested

This article is from The Cancer Letter archive.

Vol. 05 No. 35 | August 31, 1979

Download PDF Visit The Full Archive

Related Articles

GAO Report Finds Hydrazine Sulfate Trials Were Accurate

September 29, 1995

In Brief: Board Subcommittee Meetings On Comprehensive Centers Postponed; FDA Committee Uncharted

March 10, 1978

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

December 16, 2011

Science Policcy: HHS Concludes NIH May und Human Stem Cell REsearch

January 22, 1999

Cancer Centers Branch To Be ‘More Proactive,’ Kimes Tells NCAB

January 5, 1990

Unorthodox Panel Considers NIH Mandated Role In Study of Unconventional Medical Practices

June 26, 1992